The Michener Institute

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

Retrieved on: 
Thursday, April 27, 2023
DFU, PAU, Extracorporeal shockwave therapy, SAWC, ESWT, Health, Foot, OTCQB, TMI, The Michener Institute, SOC, DLS, Brazil, Regenerative medicine, WHS, Ministry, Ministry of Health, Welfare and Sport, Ministry of Trade, Industry and Energy, Hendricks, ICT, Microcirculation, EDEN, Plantar fasciitis, FDA, Standard of care, Ministry of Science and ICT, National Harbor, Maryland, Pharmaceutical industry, Nursing, Science, MD, Patient

EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference.

Key Points: 
  • EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference.
  • The SAWC Spring | WHS conference is the premier event dedicated to the management, treatment, and prevention of wounds, and brings together leading wound care experts from around the world.
  • The conference offers an opportunity for participants to share ideas and learn about the latest advancements in wound care technology.
  • "We are excited to attend the 2023 SAWC Spring | WHS conference and to participate in such an important event," said Tim Hendricks, Executive Vice President, Wound Care US of SANUWAVE Health.

18th Grand Cru Culinary Wine Festival raises more than $59 million for University Health Network

Retrieved on: 
Tuesday, November 1, 2022
Aston, Heart, CEO, ECN Capital, Health, Donald, Brain, Research, Blood, University Health Network, Eye, Education, Food, Car, UHN, Toronto Western Hospital, Wine, History, Michelin, Cru (wine), The Michener Institute, Toronto Rehabilitation Institute, Grand cru, Trustee, Diabetes, Pharmaceutical industry, Restaurant, Medicine

The 'Grand Cru' of fundraising: 18 years and $127 million

Key Points: 
  • The 'Grand Cru' of fundraising: 18 years and $127 million
    An eclectic and delicious three-day weekend full of festivities, Grand Cru Culinary Wine Festival is the largest event of its kind.
  • The spectacular Grand Cru Live Auction featured during the tasting, raised more than $1.3 million.
  • "The Grand Cru Culinary Wine Festival has featured the future of Canadian health care on its exclusive menu since 2005, raising more than $127 million.
  • Part of University Health Network (UHN), UHN Foundation raises funds for research, education and the enhancement of patient care at Toronto General and Toronto Western hospitals, Toronto Rehab and The Michener Institute of Education at UHN.

DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application

Retrieved on: 
Tuesday, November 30, 2021
Patient, CEO, Toronto Rehabilitation Institute, UHN, University, European Medicines Agency, Radiopharmaceutical, Lymphoma, Lung cancer, The Michener Institute, Toronto Western Hospital, Diagnosis, News, Center, Partnership, Cancer, CXCR4, DGAP, Cardiology, Education, TecDAX, Deutsch, Clinical Ovarian Cancer & Other Gynecologic Malignancies, Physician, University Health Network, Commercialization, Research, Health, EMA, Arthritis, ISIN, PET, Neuroscience, Transplant, Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act, Infection, Oncology, Nuclear medicine, Security (finance), Pharmaceutical industry, Medical imaging, Eckert & Ziegler, CanProbe, ECKERT & ZIEGLER, CANPROBE

The partnership involves clinical research to further advance PentixaPharm's Ga-68 radiodiagnostic tracer PENTIXAFOR in its detection of different tumour entities and other diseases.

Key Points: 
  • The partnership involves clinical research to further advance PentixaPharm's Ga-68 radiodiagnostic tracer PENTIXAFOR in its detection of different tumour entities and other diseases.
  • Eckert & Ziegler (ISIN DE0005659700, TecDAX) and its subsidiary, PentixaPharm GmbH, are working with CanProbe and UHN to provide PENTIXAFOR to patients in Toronto.
  • The intent is to provide further support toward the approval of PENTIXAFOR as a diagnostic agent for a portfolio of different indications.
  • "We are delighted to see this partnership emerging between PentixaPharm, CanProbe, and UHN", adds Luke Brzozowski, Senior Director, Techna and Diagnostics Innovation, University Health Network.

ARTMS Inc. Announces Health Canada Submission for Ga-68 Production and Tri-party Collaboration to Advance Ga-68 Imaging Products

Retrieved on: 
Thursday, October 14, 2021
Technology, Research, Medical Devices, Other Technology, Biotechnology, Health, Pharmaceutical, Science, Oncology, The Michener Institute, Toronto Western Hospital, Princess Margaret Cancer Centre, Transplant, Nuclear medicine, Center, UHN, File, HC, PET, University, Network, Research, McMaster University, Risk, Cancer, NEPAD African Western and Southern Networks of Centres of Excellence in Water Sciences, Marketed Health Products Directorate, Infection, Patient, Health Canada, CEO, Ontario Institute for Cancer Research, Prostate cancer, Positron emission tomography, Diagnosis, University Health Network, LinkedIn, Radiopharmaceutical, Health, Gallium, Education, NCE, Radionuclide, NASDAQ, PNT, Invention, Cardiology, Actinium-225, Toronto Rehabilitation Institute, Arthritis, Neuroscience, Commercialization, Medical imaging, Hospital, ARTMS, POINT Biopharma, CanProbe, ARTMS, POINT BIOPHARMA, CANPROBE

ARTMS Health Canada filing will help alleviate the current supply constraints and provide innovators the ability to advance new radiopharmaceutical drugs into development.

Key Points: 
  • ARTMS Health Canada filing will help alleviate the current supply constraints and provide innovators the ability to advance new radiopharmaceutical drugs into development.
  • The Ga-68 regulatory filing in Canada is the next step in ARTMS goal to prevent the significant supply issues of this important medical isotope.
  • Any interruptions to the supply chain will negatively impact patients and drug innovators, explained Charles S. Conroy, Chief Executive Officer of ARTMS.
  • We believe ARTMS solid target approach to Ga-68 production will play a key role in increasing the availability of this important isotope.

Villa Charities Inc. Appoints Marco DeVuono President and CEO

Retrieved on: 
Thursday, September 9, 2021

TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Villa Charities Inc. is pleased to announce the appointment of Marco DeVuono to the position of President and CEO, effective immediately.

Key Points: 
  • TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Villa Charities Inc. is pleased to announce the appointment of Marco DeVuono to the position of President and CEO, effective immediately.
  • Mr. DeVuono joined Villa Charities as Chief Financial Officer in March 2017 and has been instrumental in the companys success and growth during his tenure.
  • I am honoured to accept this new leadership position and to further advance Villa Charities strategic priorities, with a focus on the pillars of community, fundraising and stewardship, says Marco DeVuono.
  • Each of these organizations is an integral part of the Villa Charities family with separate legal status and its own governance Board.

Toronto General Hospital Deploys Vocera Smartbadge to Protect and Connect Care Teams During COVID-19 Patient Surges

Retrieved on: 
Thursday, July 8, 2021
Health, Medical devices, Technology, Hospitals, Telecommunications, Mobile, Wireless, Hardware, Hospitals, University Health Network, Princess Margaret Cancer Centre, The Michener Institute, Toronto Rehabilitation Institute, ONTARIO, Toronto General Hospital, Toronto, Michener, UHN, Trademark, Marketing

Clinicians can connect with the right person or group quickly and safely, saving critical time and resources.

Key Points: 
  • Clinicians can connect with the right person or group quickly and safely, saving critical time and resources.
  • It is our mission to help protect and connect care team members, so they dont feel isolated or alone.
  • University Health Network consists of Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and The Michener Institute of Education at UHN.
  • Vocera and the Vocera logo are trademarks of Vocera Communications, Inc. registered in the United States and other jurisdictions.